
Geotricum candidum on SDA as shown above picture. Colony characteristics on SDA are fast-growing, flat, white to cream, dry, and finely suede-like with no reverse pigment as shown above picture.
Geotricum candidum is an extremely common fungus and worldwide in distribution. It is normal human flora and was first described in 1809 by Johann Heinrich Friedrich Link and isolated from sputum and feces. Geotricum candidum showing arthroconidium in LPCB mount as shown above picture. Hyphae are hyaline, septate, branched, and break up into chains of hyaline, smooth, one-celled, subglobose to cylindrical arthroconidia. They are 6-12× 3-6 µm in size. They are released by the separation of a double septum.
(Described by Link ex Persoon in 1822)
Note: The genus, Geotricum includes several species among them medically important species are Geotricum candidum and Geotricum capitatum.
Risk group: It comes in risk group 1 organism.
Geotrichosis is a fungal disease and its causative agent Geotricum candidum. The most important risk factor for invasive fungal infection related to Geotrichum is severe immunosuppression. Its involvement is especially in hematological malignancies as acute leukemia, associated with profound and prolonged neutropenia. Fungemia is very common, often with deep organ involvement like lung, liver, spleen, and central nervous system. Its involvement is also in skin and mucous membranes lesions.
It can cause the following infections-
Mortality rate: Mortality associated with Geotricum-related infections is high, ranging from 57% to 80%.
Specimen: It depends on the nature of infection involvement.
There is no optimal treatment for Geotricum infections.
Following antifungal agents are applicable for antifungal susceptibility testing-
Fluconazole
Intraconazole
Voriconazole
Amphotericin B and
Flucytosine.
But according to existing data guidelines recommend amphotericin B with or without co-administered flucytosine or with voriconazole showing well in vitro susceptibility.
G. candidum G. capitatum